V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20177553 | 20175818 | 1.79 | 102 | Curative (C) | 2020-08-31 | 2020-09-01 | SOTORASIB | 02 | N | IXAZOMIB + LENALIDOMIDE | 100565509 |
| 20178873 | 20175819 | 1.6 | 69.6 | null | 2016-11-20 | 2017-01-01 | ETOPOSIDE | 02 | null | TOPARP TRIAL | 100843706 |
| 20180926 | 20175820 | 1.54 | 93.4 | Palliative (P) | 2019-12-09 | 2019-12-11 | EOF | 02 | N | TEYSUNO | 100350853 |
| 20183306 | 20175823 | 1.62 | 91.1 | Curative (C) | 2021-04-14 | 2021-10-22 | Doxorubicin + Olaratumab | 01 | N | BACILLUS CALMETTE-GUERIN | 100379481 |
| 20184308 | 20175824 | 1.8 | 93 | 03 | 2022-02-02 | 2022-03-16 | CISPLATIN + EPIRUBICIN | 02 | N | VINORELBINE | 100669532 |
| 20184560 | 20175825 | 1.83 | 97.7 | 03 | null | 2019-10-03 | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 01 | N | CARBOPLATIN + VINORELBINE | 101540921 |
| 20184820 | 20175826 | 1.86 | 85.4 | null | null | 2016-07-23 | Venetoclax | 02 | N | TEMOZOLOMIDE | 100129984 |
| 20185965 | 20175827 | 1.7 | null | null | 2022-01-20 | 2022-01-23 | Epirubicin | 02 | null | RITUXIMAB | 101692704 |
| 20186389 | 20175828 | 1.81 | 51.6 | null | 2019-02-10 | 2019-12-28 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | ISATUXIMAB + POMALIDOMIDE | 101404371 |
| 20191722 | 20175830 | 1.56 | 87 | null | 2018-11-03 | 2019-08-10 | Bevacizumab + Irinotecan + MdG | 02 | null | OLAPARIB | 100789396 |
| 20192517 | 20175831 | 1.78 | 66.9 | Adjuvant (A) | 2020-01-16 | 2020-01-24 | ARISTOTLE TRIAL | 02 | N | IBRUTINIB | 100811264 |
| 20192633 | 20175832 | 1.75 | 83.2 | null | 2018-10-11 | 2018-10-28 | Gemcitabine + Paclitaxel | 02 | N | CAPECITABINE + MITOMYCIN + RT | 100468754 |
| 20193514 | 20175835 | 1.65 | 60.85 | Palliative (P) | 2019-08-30 | 2019-09-06 | CAP + RT | 02 | N | PHITT D SIOPEL-4 (A1, A2, A3) | 100967649 |
| 20193552 | 20175836 | 1.75 | 73.6 | Adjuvant (A) | 2018-09-28 | 2020-01-25 | FOXTROT TRIAL | 02 | null | FOCUS4 TRIAL | 100636346 |
| 20193638 | 20175837 | 1.54 | 78 | Palliative (P) | 2020-01-09 | 2020-01-16 | CHOP R | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 101825471 |
| 20193816 | 20175838 | 1.57 | 75.8 | null | 2019-11-07 | 2019-11-25 | CISPLATIN + RALTITREXED | 02 | N | DARATUMUMAB | 100567206 |
| 20194172 | 20175839 | 1.45 | 94.6 | 03 | 2018-01-23 | 2018-01-23 | CAV | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100352389 |
| 20194533 | 20175841 | 1.79 | null | Palliative (P) | 2018-01-08 | 2018-01-08 | CHOP R | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPATIN | 100062470 |
| 20194746 | 20175842 | 1.49 | 75.9 | null | 2016-12-17 | 2017-01-07 | MITOMYCIN | 02 | null | POMALIDOMIDE | 101348927 |
| 20195081 | 20175843 | 1.58 | 63 | Adjuvant (A) | 2017-12-21 | 2019-03-29 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | ECARBOX | 100873840 |
| 20195682 | 20175844 | 1.8 | 49 | Palliative (P) | 2018-08-07 | 2018-08-17 | Atezolizumab | 02 | null | EPIRUBICIN | 100723794 |
| 20197298 | 20175845 | 1.86 | 83 | Palliative (P) | 2020-08-11 | 2020-08-11 | MIC | 02 | N | GEFITINIB | 101227674 |
| 20197652 | 20175846 | 1.61 | 48.8 | Palliative (P) | 2018-10-14 | 2018-10-17 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | BORTEZOMIB | 101151692 |
| 20197694 | 20175847 | 0 | 77 | Palliative (P) | 2019-09-25 | 2020-04-28 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 100150951 |
| 20198126 | 20175848 | 1.69 | 68.8 | Palliative (P) | 2021-01-11 | 2021-02-02 | FLUOROURACIL + Panitumumab | 02 | N | CARBOPLATIN + VINORELBINE | 100341536 |
| 20198192 | 20175849 | 1.76 | 67.7 | null | 2019-03-16 | 2019-10-09 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | null | CARBOPLATIN + PEMETREXED | 100980667 |
| 20198916 | 20175850 | 1.69 | 51.6 | Palliative (P) | 2021-11-18 | 2021-12-17 | GEFITINIB | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100498854 |
| 20199648 | 20175851 | 1.81 | 62.4 | null | 2020-02-12 | 2020-03-11 | FCarboSt | 02 | null | CAPITAL TRIAL | 100122884 |
| 20199729 | 20175852 | 1.78 | 105 | Palliative (P) | 2020-06-07 | 2020-06-28 | Temozolomide 150mg/m2 | 02 | N | IBRUTINIB | 100995507 |
| 20200379 | 20175853 | 1.6 | 78.6 | Palliative (P) | null | 2022-03-26 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 99 | null | PAZOPANIB | 101544874 |
| 20201166 | 20175855 | 1.71 | 85 | Palliative (P) | 2015-01-05 | 2019-04-29 | CISPLATIN + FLUOROURACIL + Trastuzumab | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100687744 |
| 20201314 | 20175856 | 1.57 | 78 | null | 2018-10-02 | 2018-10-10 | OXALIPLATIN + MDG + PANITUMUMAB | 01 | N | EC | 101256435 |
| 20202435 | 20175857 | null | 50.4 | Palliative (P) | 2021-07-03 | 2021-07-17 | Cape+Cetuximab+Oxalip (2 wk) Maint | 02 | N | BUSULFAN | 101699061 |
| 20203204 | 20175859 | 1.48 | null | Palliative (P) | 2021-01-09 | 2021-02-21 | CAV | 02 | null | ETOPOSIDE | 101602500 |
| 20203627 | 20175860 | 1.6 | 48.2 | null | 2022-04-06 | 2022-04-10 | CHOP R - 21 days | 02 | N | POMALIDOMIDE | 101042890 |
| 20204380 | 20175862 | 1.57 | 101.6 | null | 2019-10-14 | 2019-12-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100099922 |
| 20204423 | 20175863 | 1.84 | 84.3 | null | 2021-12-08 | 2022-01-06 | EOF | 02 | null | ECARBOX | 100383333 |
| 20205252 | 20175865 | 1.86 | 76.3 | Palliative (P) | 2021-08-31 | 2021-10-12 | IBRUTINIB | 02 | null | CABAZITAXEL | 101853630 |
| 20205674 | 20175866 | 1.77 | 98.15 | null | 2020-01-16 | 2020-02-11 | Bevacizumab + Capecitabine | 02 | null | BACILLUS CALMETTE-GUERIN | 101791858 |
| 20206048 | 20175868 | 1.72 | 72.5 | Palliative (P) | 2017-09-18 | 2019-12-29 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | Y | ARISTOTLE TRIAL | 101257517 |
| 20206119 | 20175869 | 1.71 | 56.4 | Palliative (P) | 2017-06-07 | 2018-02-08 | Hepatoblastoma SR Cisplatin | 01 | null | MITOMYCIN | 100637538 |
| 20206443 | 20175870 | 1.75 | null | Palliative (P) | 2018-02-15 | 2019-01-04 | null | N | null | CAPECITABINE + LOMUSTINE | 101450822 |
| 20206480 | 20175871 | 1.91 | 80.8 | null | 2018-07-13 | 2018-07-13 | Trastuzumab + VINORELBINE | 02 | null | ECF | 100364677 |
| 20206530 | 20175872 | null | 52 | Neo-adjuvant (N) | 2019-05-08 | 2019-05-09 | CABOZANTINIB | N | N | PEMBROLIZUMAB + PEMETREXED | 101395576 |
| 20206644 | 20175873 | 1.83 | 72 | Palliative (P) | 2019-12-09 | 2019-12-22 | Bevacizumab + Oxaliplatin +MdG | null | N | THALIDOMIDE | 101417379 |
| 20207633 | 20175874 | 0 | 0 | Palliative (P) | 2018-02-20 | 2018-09-20 | Cisplatin + Radiotherapy | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101468877 |
| 20207941 | 20175875 | 1.58 | 86.1 | Adjuvant (A) | 2020-06-12 | 2020-07-02 | Carboplatin + Raltitrexed | null | Y | IPILIMUMAB + NIVOLUMAB | 100556932 |
| 20208048 | 20175876 | 1.8 | 86.3 | Palliative (P) | 2018-01-19 | 2018-02-16 | Fluorouracil + Folinic + RT Bossett | 02 | N | CISPLATIN + TRASTUZUMAB | 101311813 |
| 20208403 | 20175877 | 1.52 | 69 | Neo-adjuvant (N) | 2021-11-14 | 2022-03-11 | Cisplatin + Vinorelbine (IV) | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101228832 |
| 20208450 | 20175878 | 1.51 | 78.5 | Palliative (P) | 2020-11-18 | 2020-11-22 | CETUXIMAB + IRINOTECAN | 02 | N | ECARBOX | 101828578 |